BUSINESS
Bullish to Sell Three Equiniti Units to Siris in 2027 Deal
Siris has exercised its option to buy three non-core Equiniti business lines as Bullish moves closer to closing its full Equiniti acquisition.
EDITOR'S PICKS
Markets
View all 6 →Economy
View all 1 →Business
View all 6 →Personal Finance
View all 6 →FDA Panel Backs Compounding Six Popular Peptides for Wider Access
An FDA advisory panel voted to allow six peptides to be compounded, potentially expanding access to popular wellness treatments for Americans.
MOST READ
-
1
BUSINESS
Bullish to Sell Three Equiniti Units to Siris in 2027 Deal
-
2
PERSONAL FINANCE
FDA Panel Backs Compounding Six Popular Peptides for Wider Access
-
3
BUSINESS
Outdoor Retailer Files Chapter 11, Closing 91 Stores Nationwide
-
4
PERSONAL FINANCE
Should High-Earning Retirees Be Able to Opt Out of Social Security?
-
5
MARKETS
LondonMetric and Schroder Form Real Estate Consortium Deal